Your Messages Inbox
Most Viewed Abstracts
1. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 2. Omega-3 fatty acids for bipolar disorder 3. Is folic acid good for everyone 4. ACS Releases Guidelines for HPV Vaccination 5. Vitamin D - A review Free full text
Your Article Summary
See Latest ArticlesPrevention of atherosclerosis with low-density lipoprotein cholesterol lowering—lipoprotein changes and interactions: the SANDS study
Journal of Clinical Lipidology, 10/14/09
Howard WJ et al. – In diabetic adults with no previous cardiovascular events, treatment to current targets for lipids and systolic blood pressure reduces atherosclerosis progression and when more aggressive targets are met, atherosclerosis regresses. The aggressive targets for LDL–C and non–HDL–C appeared to be the main determinants of CIMT regression and were more predictive of this outcome than changes in LDL–P or apoB.
Related Articles
Heat-shock protein 90: A novel autoantigen in human carotid atherosclerosis
Atherosclerosis, 11/12/09
Relevance Score: 91%
Microarray analysis of senescent vascular smooth muscle cells: A link to atherosclerosis and vascular calcification
Experimental Gerontology, 11/12/09
Relevance Score: 89%
Effects of High-Dose Modified-Release Nicotinic Acid on Atherosclerosis and Vascular Function: A Randomized, Placebo-Controlled, Magnetic Resonance Imaging Study
JACC - Journal of the American College of Cardiology, 10/29/09
Relevance Score: 89%
Periodontal treatment influences risk markers for atherosclerosis in patients with severe periodontitis
Atherosclerosis, 10/09/09
Relevance Score: 89%
Liver X Receptors as potential therapeutic targets in atherosclerosis
Clinical and Investigative Medicine, 10/06/09
Relevance Score: 89%
Today in Atherosclerosis/Lipids...keeping you current
Receive free subspecialty "5-minute updates" via email
Cardiovascular and Economic Outcomes After Initiation of Lipid-Lowering Therapy With Atorvastatin vs Simvastatin in an Employed Population
Mayo Clinic Proceedings, 12/11/09
Subclinical Atherosclerosis In Young beta-thalassemia Major Patients
Hemoglobin, 12/11/09
Year Two Assessment of Fenofibric Acid and Moderate-Dose Statin Combination: A Phase 3, Open-Label, Extension Study
Clinical Drug Investigation, 12/11/09
Sponsor
Article Search
Sponsor
Sponsor